FDA: Authorizations of Emergency Use of Two Biological Products During the COVID-19 Pandemic; Availability

Notice from the Food and Drug Administration (FDA) announcing the issuance of Emergency Use Authorizations for biological products for use during the COVID-19 pandemic, one for Pfizer, Inc. and another for ModernaTX, Inc. These authorizations are effective on their date of issuance.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news